Abstract
The ROMICAT-II trial shows that CT coronary angiography is safe and fast for the exclusion of clinically significant obstructive coronary artery disease in low-risk patients with acute chest pain. Several issues and questions relating to the low prevalence of disease and the actual benefit to patients remain to be answered.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 615-616 |
Number of pages | 2 |
Journal | Nature Reviews Cardiology |
Volume | 9 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2012 |
Research programs
- EMC NIHES-03-30-01